NASDAQ:IMUN

Imunon Shares Trade Early After CEO Gets Stock Grant

Imunon Shares Trade Early After CEO Gets Stock Grant

Imunon shares rose 3.5% to $2.38 in thin pre-market trading Thursday after an SEC filing showed CEO Stacy Lindborg received 1,491 shares instead of part of her cash salary. The company has warned of “substantial doubt” about its ability to continue operating. Only 531 shares changed hands pre-market. Imunon’s main drug, IMNN-001, remains in Phase 3 trials for advanced ovarian cancer.
May 28, 2026

Stock Market Today

  • Europe Market Volatility Spurs Vigilant Trading Activity
    May 28, 2026, 8:46 AM EDT. Europe's markets experienced significant volatility, prompting traders to closely monitor every move. The sudden market jolt affected multiple sectors, driving heightened caution among investors. Market participants are adjusting strategies amid uncertainty influenced by geopolitical and economic factors. This vigilance reflects the increased sensitivity to rapid shifts in European financial markets, impacting trading volumes and risk management approaches across exchanges. Observers note that such volatility often signals deeper market recalibrations, with potential implications for broader economic trends and investor sentiment.